Dongmei Zhang

State Key Laboratory Of Bioactive Molecules And Druggability Assessment
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

A systematic review on the application, phytochemistry and pharmacological activities of the genus Atractylodes.

A systematic review on the application, phytochemistry and pharmacological activities of the genus Atractylodes.

Journal: Chinese medicine
Published: April 29, 2026

Dual-targeting evodiamine analogue overcomes pancreatic cancer immunotherapy resistance by inducing immunogenic cell death.

Dual-targeting evodiamine analogue overcomes pancreatic cancer immunotherapy resistance by inducing immunogenic cell death.

Journal: Biochemical pharmacology
Published: February 22, 2026

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges.

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges.

Journal: British journal of pharmacology
Published: September 24, 2025

Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy.

Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy.

Journal: Science bulletin
Published: August 28, 2025

Targeting TCF21-TCF3 heterodimer in tumor-associated pericytes attenuates hematogenous metastasis by restoring pericyte gatekeeper function.

Targeting TCF21-TCF3 heterodimer in tumor-associated pericytes attenuates hematogenous metastasis by restoring pericyte gatekeeper function.

Journal: Cell reports. Medicine
Published: July 24, 2025

Targeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche.

Targeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche.

Journal: Acta pharmaceutica Sinica. B
Published: July 21, 2025

AANG: A natural compound formulation for targeting macrophage-myofibroblast transition in non-small-cell lung carcinoma.

AANG: A natural compound formulation for targeting macrophage-myofibroblast transition in non-small-cell lung carcinoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 19, 2025

Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.

Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.

Journal: International journal of molecular sciences
Published: July 10, 2025

Special Issue "Advances in Targeted Cancer Therapy and Mechanisms of Resistance-2nd Edition".

Special Issue "Advances in Targeted Cancer Therapy and Mechanisms of Resistance-2nd Edition".

Journal: International journal of molecular sciences
Published: June 27, 2025

Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.

Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.

Journal: Nature communications
Published: May 30, 2025

Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics.

Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics.

Journal: Journal of cellular and molecular medicine
Published: March 21, 2025

Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis.

Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 14, 2025
Showing 1-12 of 57

Last Updated: 09/26/2026